Navigation Links
CVS/pharmacy and MinuteClinic Reach Goal of Delivering One Million Flu Vaccinations
Date:12/8/2008

Chief Nursing Officer for MinuteClinic. "But those who wait too long, or choose not to get vaccinated at all risk time away from work, school and other activities and the possibility of hospitalization or an even more serious outcome."

Those at highest risk for the flu include individuals with chronic diseases such as diabetes, asthma and heart disease; women who are pregnant; health care workers and young children. MinuteClinic offers vaccinations to children over 18 months in most cases. Preservative-free children's vaccinations are available at most MinuteClinic locations while supplies last.

This year, the CDC Advisory Committee on Immunization Practices has endorsed influenza vaccination for all children ages 6 months to 18 years and public health agencies have reinforced the importance of protecting children during the flu season. In some cases, local departments of health are also recommending flu vaccine for certain populations. For example, in New Jersey, a new law requires children ages 6 to 59 months who are enrolled in a licensed child-care center or pre-school facility to receive at least one dose of influenza vaccine by December 31.

The CVS flu shot survey found that 53 percent of adults with children under 18 in their household plan to get them a flu shot with the rate increasing to 60 percent for those with children under 12.

Flu shots at MinuteClinic are $30 and may be covered in whole or in part by insurance. MinuteClinic health care centers are staffed by masters- prepared, board-certified nurse practitioners and physician assistants who specialize in family health care.

About CVS Caremark

CVS Caremark is the largest provider of prescriptions in the nation. The Company fills or manages more than 1 billion prescriptions annually. Through its unmatched breadth of service offerings, CVS Caremark is transforming the delivery of health care ser
'/>"/>

SOURCE CVS Caremark
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. CVS/pharmacy Raising Funds for the St. Jude Childrens Research Hospital(R) Thanks and Giving(R) Campaign to Support Expanded Rehabilitation Services Center
2. Video: CVS/pharmacy and National Council on Aging Help Seniors to Find the Right Prescription for Medicare Savings
3. CVS/pharmacy Helps Patients Manage Diabetes Care
4. CVS/pharmacy Launches Beauty 360
5. CVS/pharmacy Announces Pharmacy Health Care Savings Program Targeted at the Uninsured
6. CVS/pharmacy Re-Opens 64 Stores in Louisiana
7. CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign
8. Howard University and CVS/pharmacy Announce Ribbon Cutting for the Howard University Pharmacy Practice Laboratory
9. CVS/pharmacy Delivers Disaster Relief in Iowa Communities Impacted by Recent Flooding
10. CVS/pharmacy Makes It Easier for Consumers to Save Money and Track Spending with Health Savings and Flexible Spending Accounts
11. Shining a Light on Sunscreen: Sun Protection Misconceptions Unveiled by Dr. Jeffrey Dover and CVS/pharmacy
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10BioCryst Provides Update Regarding Peramivir for Influenza 5116 1BioCryst Provides Update Regarding Peramivir for Influenza 5116 2BioCryst Provides Update Regarding Peramivir for Influenza 5116 3BioCryst Provides Update Regarding Peramivir for Influenza 5116 4BioCryst Provides Update Regarding Peramivir for Influenza 5116 5Study explores how life experiences contribute to the biological changes of Alzheimers 10197 1Study explores how life experiences contribute to the biological changes of Alzheimers 10197 2Study explores how life experiences contribute to the biological changes of Alzheimers 10197 3Doctor Visits Are Getting Short Shrift in Tight Economy 58589 1Doctor Visits Are Getting Short Shrift in Tight Economy 58589 2